| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.4 - Respiratory Symptoms, Diagnosed | 2014 | Iran, Islamic Republic of | IgE | 92 | 7.600 | 20140811, Teifoori F
| | 1.4 - Respiratory Symptoms, Diagnosed | 2014 | Italy | IgE | 21 | 76.200 | 20141114, Costa C
| | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 4.000 | 20140821, Choi JS
| | 1.9 - Pollen Allergy | 2014 | Czech Republic | IgE | 826 | 9.300 | 20140606, Panzner P
| | 5.2.5 - Source Exposed, Children (Symptoms, IgE) | 2014 | Spain | IgE | 55 | 96.920 | 20140618, Cases B
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 17.100 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 40.000 | 20130605, Simon D
| | 1.4 - Respiratory Symptoms, Diagnosed | 2013 | Spain | IgE | 187 | 36.400 | 20131016, Feliu A
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 7.860 | 20130111, Ott H
| | 4.1.3 - Heterologous Source Sensitized (SPT) | 2013 | Italy | IgE | 17 | 70.590 | 20131031, Bonura A
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2013 | Spain | IgE | 175 | 81.000 | 20130807, Letran A
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 0.000 | 20120528, Patelis A
| | 1.4 - Respiratory Symptoms, Diagnosed | 2012 | France | IgE | 129 | 36.400 | 20121204, Caimmi D
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Austria | IgE | 54 | 44.400 | 20120310, Twaroch TE
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Italy | IgE | 26 | 46.200 | 20120310, Twaroch TE
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 233 | 66.700 | 20120726, Flores E
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 55 | 63.600 | 20120726, Pedrosa M
| | 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2012 | Spain | IgE | 68 | 52.900 | 20120726, Pedrosa M
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 18.180 | 20110223, De Knop KJ
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.810 | 20120528, Patelis A
| | 1.4 - Respiratory Symptoms, Diagnosed | 2011 | Spain | IgE | 68 | 48.500 | 20110509, Rodriguez D
| | 3.1.1 - Source Sensitized (SPT) | 2011 | Italy | IgE | 46 | 69.560 | 20110727, Asero R
| | 4.1.2 - Heterologous Source Sensitized (Symptoms, SPT) | 2011 | China | IgE | 100 | 1.000 | 20111214, Zheng YW
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Spain | IgE | 98 | 90.800 | 20110304, Garcia BE
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Spain | IgE | 85 | 28.200 | 20110304, Garcia BE
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 22.090 | 20101214, Gadisseur R
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Italy | IgE | 16408 | 19.550 | 20100301, Scala E
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 15.000 | 20091005, Ott H
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 3.850 | 20091121, Ebo DG
| | 3.1.4 - Source Sensitized (SPT, IgE) | 2009 | Spain | IgE | 53 | 92.500 | 20100204, Belver MT
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 0.000 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 35.000 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 13.510 | 20090826, Ebo DG
| | 1.4 - Respiratory Symptoms, Diagnosed | 2008 | Spain | IgE | 786 | 74.050 | 20081010, Barber D
| | 5.2.1 - Source Exposed (Symptoms, SPT) | 2008 | Spain | IgE | 146 | 91.800 | 20081009, Llanes E
| | 3.1.4 - Source Sensitized (SPT, IgE) | 2002 | Spain | IgE | 71 | 80.000 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 2002 | Spain | IgE | 119 | 84.000 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 2002 | Spain | SPT | 134 | 92.500 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 2002 | Spain | SPT | 119 | 90.700 | | | 5.2.1 - Source Exposed (Symptoms, SPT) | 2001 | Spain | IgE | 46 | 75.000 | | | 5.4.2 - Source Exposed (Symptoms, SPT, high IgE) | 1999 | Spain | IgE | 164 | 71.000 | | | 5.4.2 - Source Exposed (Symptoms, SPT, high IgE) | 1998 | Spain | IgE (IB) | 20 | 40.000 | |
|
Loading...
Ole e 1
